Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
Clinical trial NCT06182358 · COMPLETED
Trial details
- NCT number
- NCT06182358
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-27
- Primary completion
- 2025-01-27
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.